Why is Senores Pharma. falling/rising?

As of 25-Jun, Senores Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 571.95, reflecting a rise of Rs 41.55 or 7.83%. The stock has outperformed its sector by 6.78% today and has shown a consecutive gain over the last four days, accumulating a total return of 10.84% during this period. Additionally, the stock is trading above its moving averages across various time frames, indicating a strong upward trend. However, there is a noted decline in investor participation, with delivery volume falling by 22.15% against the five-day average. Despite a low debt-to-equity ratio and impressive long-term growth in net sales and operating profit, the stock's valuation appears expensive, and institutional investors have reduced their stakes, which may be contributing to mixed sentiments among investors.
In the broader market context, Senores Pharmaceuticals has outperformed the Sensex over the past week and month, with returns of 7.21% and 12.81%, respectively, compared to the benchmark's 1.61% and 1.27%. This strong performance in the short term suggests that the stock is gaining traction relative to the overall market. However, the year-to-date return of 0.54% for the stock lags behind the Sensex's 5.91%, indicating that while recent momentum is positive, the stock has not performed as well over a longer time frame. The decline in institutional investor participation may also reflect broader market caution, which could impact future price movements.